Giriş: Dünya Sağlık Örgütü (WHO) ve Birleşmiş Milletler Çocuklara Yardım Fonu (UNICEF), 6. ayda ek besinlere başlayarak emzirmenin 2 yaşına kadar sürdürülmesini önermektedir. Çalışmamızdaki amacımız 0-2 yaş arası çocuklardaki beslenme alışkanlıklarını ve annelerinin beslenme konusundaki bilgi düzeylerini değerlendirmektir. Yöntem: Tanımlayıcı nitelikteki bu çalışmaya 0-2 yaş bebeği olan toplam 250 anne dahil edildi. Annelere, sosyodemografik özelliklerin, anne sütünün, ek besinlerin ve bu konularda annelerin bilgi düzeyinin değerlendirildiği bir anket formu verildi. Ardından bebeklerin boy-kilo ölçümleri yapıldı. Araştırmadan elde edilen veriler SPSS 16,0 istatistik programı kullanılarak değerlendirildi, istatistiksel analizlerde tanımlayıcı analizler ve ki-kare testi kullanıldı. p<0,05 anlamlılık sınırı olarak kabul edildi. Bulgular: Bebeklerin %84,3’ü ilk 1 saat içinde anne sütü almıştır. %41.3’ü 3-6 ay arası anne sütü alırken, %16,5’inde 6 aydan önce anne sütü kesilmiştir. Bebeklerin %50,8’i mama ile beslenmiş, %49,2’sine ise biberon verilmiştir. Bebeklerin %25,6’sına 6 aydan önce, %51,2’sine ise 6 aydan sonra ek gıda başlanmıştır. Anne eğitimi ile anne sütü hakkında bilgi, ek gıda hakkında bilgi, anne sütü kesilme zamanı ve bebek kilo persentili arasında fark bulunmuştur. Sonuç: Annelerin anne sütü ve tamamlayıcı beslenme konusundaki bilgi düzeyleri ne kadar iyi olursa toplumun da bilgi düzeyi o kadar artış gösterecek ve davranışlarına yansıyacaktır.

Considering the aging population, the increase in predisposing factors, and the improvement in healthcare with increased survival rates, atrial fibrillation has been the most common cardiac arrhythmia in adults with a rise in the estimated lifetime risk over recent years. While aging is a powerful risk factor for atrial fibrillation, the leading prevalent comorbidities are hypertension, heart failure, obesity, obstructive sleep apnea, diabetes mellitus, and chronic kidney disease. Atrial fibrillation is associated with substantial morbidity, impaired quality of life, and increased mortality and healthcare costs. As a significant proportion of the total atrial fibrillation population is asymptomatic or mildly symptomatic, early identification and initiation of appropriate treatment for atrial fibrillation may prevent potentially detrimental outcomes such as stroke and heart failure and decrease all-cause mortality. Although screening via evolving health technologies has recently been emerging, verification of the electrocardiogram track recording over at least 30 seconds by a physician with expertise is still required for a definite diagnosis. Based on the global and national data and the current healthcare environment in Turkey, this targeted review with cardiology, neurology, and family physicians’ perspectives highlights the importance of early detection by implementing the advancing screening modalities as well as the need for raised awareness of both patients and healthcare professionals and establishment of a multidisciplinary clinical approach for a better outcome in atrial fibrillation management.

Ibed and their side-effects in Turkish population. We aimed to investigate the usage and side-effects of drugs with anticholinergic properties in patients over 65 years of age attending to primary care centers. Materials and Methods: Five hundred and sixty-three subjects were interviewed with a questionnaire of 16 questions inquiring their medication and possible side-effects. Timed up and go test (TUGT) and standardized mini-mental test (SMMT) were also performed. Results: Medical records of 563 individuals were screened to detect anticholinergic medication. Twenty-eight patients were using anticholinergic medication. Mean duration of anticholinergic medication usage was 3.17 years. Mean number of falls occurred in the previous year was 1.14 ± 1.17. Mean SMMT score was 27.20 ± 1.13. Mean TUGT scores mean was 12.4 ± 1.25. Drowsiness in 18 patients (65%), dry mouth in 15 patients (53%), dry eyes in 15 patients (53%), constipation in 11 patients (39%), blurred vision in 11 patients (%39), urinary hesitancy in eight patients (28%), confusion in six patients (21%) were reported. We found that none of the subjects were evaluated in terms of fall risk or mental status by their doctors before the prescription of drugs with anticholinergic effects. Conclusions: A suggested approach to improve drug safety was reported as to reduce the use of anticholinergic drugs when it is possible. Psychiatrists and family physicians should select less anticholinergic drugs for medication and have to evaluate their patients' fall risk and their cognitive status before prescribing drugs with anticholinergic side effects....